Table 3 Detection rates of 17 viruses in 74 serum samples from PRDC-affected piglets and clinically healthy controls.
Virus | No. positive/total | OR | OR 95% CI | P value | |
|---|---|---|---|---|---|
Asymptomatic samples | Animals with PRDC | ||||
PCV-2 | 44.74% (17/38) | 72.22% (26/36) | 3.22 | 1.22–8.47 | 0.01 |
PRRSV | 31.58% (12/38) | 75.0% (27/36) | 6.50 | 2.34–18.0 | <0.001 |
PRV | 2.63% (1/38) | 2.78% (1/36) | 1.48 | 0.09–24.78 | 0.65 |
PPV-2 | 52.63% (20/38) | 83.33% (30/36) | 4.50 | 1.52–13.30 | 0.005 |
PPV-3 | 13.16% (5/38) | 52.78% (19/36) | 7.38 | 2.35–23.20 | <0.001 |
PPV-4 | 7.89% (3/38) | 2.78% (1/36) | 0.33 | 0.033–3.36 | 0.33 |
PPV-5 | 7.89% (3/38) | 5.56% (2/36) | 0.68 | 0.11–4.37 | 0.53 |
PPV-6 | 36.84% (14/38) | 83.33% (30/36) | 8.57 | 2.86–25.67 | < 0.001 |
PBoV-1 | 7.89% (3/38) | 19.44% (7/36) | 2.81 | 0.67–11.88 | 0.13 |
PBoV-3 | 10.53% (4/38) | 8.33% (3/36) | 0.77 | 0.16–3.72 | 0.53 |
PBoV-5 | 7.89% (3/38) | 5.56% (2/36) | 0.69 | 0.11–4.37 | 0.53 |
TTSuV-1a | 1.84% (7/38) | 47.22% (17/36) | 3.96 | 1.39–11.31 | 0.008 |
TTSuV-1b | 36.84% (14/38) | 58.33% (21/36) | 2.40 | 0.94–6.11 | 0.052 |
PCMV | 21.05% (8/38) | 44.44% (16/36) | 3.00 | 1.08–8.32 | 0.03 |
PKV | 13.16% (5/38) | 16.67% (6/36) | 1.32 | 0.36–4.77 | 0.46 |
PAstV | 63.16% (24/38) | 83.33% (30/36) | 2.92 | 0.97–8.73 | 0.051 |
pigSCV | 5.26% (2/38) | 11.11% (4/36) | 2.25 | 0.39–13.12 | 0.31 |
